Skip to main content
Clinical Trials/CTRI/2017/09/009754
CTRI/2017/09/009754
Completed
未知

Role of Suprascapular Nerve Block versus Ultrasonic Therapy in patients with partial thickness rotator cuff tear of shoulder joint: A comparative study

IPGMER SSKM Hospital0 sites126 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
IPGMER SSKM Hospital
Enrollment
126
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 10, 2017
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
IPGMER SSKM Hospital

Eligibility Criteria

Inclusion Criteria

  • (1\) Clinical rotator cuff pathology and partial tear confirmed by ultrasonography or Magnetic Resonance Imaging.
  • (2\) Symptoms persisting for at least 4 weeks duration.
  • (3\) Pain defined as a score of 5 points or more on a 10\-cm visual analog scale (VAS) rated from 0 (no pain) to 10 (worst imaginable pain).
  • (4\) Patient mentally sound enough to communicate and participate in the study and can understand the parameters well.

Exclusion Criteria

  • (1\)Long standing ( \>16weeks) symptoms.
  • (2\) Arm Drop Sign positive.
  • (3\) Full thickness tears of the rotator cuff in ultrasonographic examination or MRI.
  • (4\) The presence of another obvious associated cause for the pain (i.e., Primary osteoarthritis of glenohumeral joint, fracture, radiculopathy, myofascial pain, central neuropathic pain)
  • (5\) Severe motor weakness (muscle power of deltoid less than grade 2 on the manual muscle test).
  • (6\) Patients with Post myocardial infarction, Post stroke, Post mastectomy, prolonged immobilization.
  • (7\) The presence of an unstable medical condition or a known uncontrolled systemic disease, including cancer, diabetes, rheumatoid arthritis, endocrine disease, major depression, schizophrenia, \& patients with persistent very high level of ESR \& CRP.
  • (8\) Patients with contraindications for UST i.e. infection in and around the joint, bacteraemia or sepsis, significant skin breakdown at the proposed therapy site, presence of a joint prosthesis etc.
  • (9\)Patients with contraindications of steroid injections i.e. overlying soft tissue sepsis, bacteraemia, anatomic inaccessibility, uncooperative patient, uncontrolled bleeding diathesis etc.
  • (10\)Patients who got intra\-articular injection in shoulder within last six months.

Outcomes

Primary Outcomes

Not specified

Similar Trials